Literature DB >> 20518079

Is the disease course predictable in inflammatory bowel diseases?

Peter Laszlo Lakatos1, Lajos S Kiss.   

Abstract

During the course of the disease, most patients with Crohn's disease (CD) may eventually develop a stricturing or a perforating complication, and a significant number of patients with both CD and ulcerative colitis will undergo surgery. In recent years, research has focused on the determination of factors important in the prediction of disease course in inflammatory bowel diseases to improve stratification of patients, identify individual patient profiles, including clinical, laboratory and molecular markers, which hopefully will allow physicians to choose the most appropriate management in terms of therapy and intensity of follow-up. This review summarizes the available evidence on clinical, endoscopic variables and biomarkers in the prediction of short and long-term outcome in patients with inflammatory bowel diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20518079      PMCID: PMC2880770          DOI: 10.3748/wjg.v16.i21.2591

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  83 in total

1.  Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease.

Authors:  A G Røseth; E Aadland; K Grzyb
Journal:  Scand J Gastroenterol       Date:  2004-10       Impact factor: 2.423

2.  Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis.

Authors:  E A Fagan; R F Dyck; P N Maton; H J Hodgson; V S Chadwick; A Petrie; M B Pepys
Journal:  Eur J Clin Invest       Date:  1982-08       Impact factor: 4.686

3.  Smoking in Crohn's disease: effect on localisation and clinical course.

Authors:  E Lindberg; G Järnerot; B Huitfeldt
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

4.  Association of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies with Vienna classification subtypes of Crohn's disease.

Authors:  Frank H Klebl; Frauke Bataille; Claudia R Bertea; Hans Herfarth; Ferdinand Hofstädter; Jürgen Schölmerich; Gerhard Rogler
Journal:  Inflamm Bowel Dis       Date:  2003-09       Impact factor: 5.325

5.  Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.

Authors:  R M Weinshilboum; S L Sladek
Journal:  Am J Hum Genet       Date:  1980-09       Impact factor: 11.025

6.  Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.

Authors:  William S Mow; Eric A Vasiliauskas; Ying-Chao Lin; Phillip R Fleshner; Konstantinos A Papadakis; Kent D Taylor; Carol J Landers; Maria T Abreu-Martin; Jerome I Rotter; Huiying Yang; Stephan R Targan
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

7.  The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study.

Authors:  M Boirivant; M Leoni; D Tariciotti; S Fais; O Squarcia; F Pallone
Journal:  J Clin Gastroenterol       Date:  1988-08       Impact factor: 3.062

8.  Effect of cigarette smoking on recurrence of Crohn's disease.

Authors:  L R Sutherland; S Ramcharan; H Bryant; G Fick
Journal:  Gastroenterology       Date:  1990-05       Impact factor: 22.682

Review 9.  Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice.

Authors:  Jacques Cosnes
Journal:  Best Pract Res Clin Gastroenterol       Date:  2004-06       Impact factor: 3.043

10.  Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype.

Authors:  E Louis; V Michel; J P Hugot; C Reenaers; F Fontaine; M Delforge; F El Yafi; J F Colombel; J Belaiche
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

View more
  7 in total

1.  Prediction of disease course in inflammatory bowel diseases.

Authors:  Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

Review 2.  Current status of thiopurine analogues in the treatment in Crohn's disease.

Authors:  Peter Laszlo Lakatos; Lajos S Kiss
Journal:  World J Gastroenterol       Date:  2011-10-21       Impact factor: 5.742

3.  Effect of childbirth on the course of Crohn's disease; results from a retrospective cohort study in the Netherlands.

Authors:  Marieke Smink; Frederik K Lotgering; Lisette Albers; Dirk J de Jong
Journal:  BMC Gastroenterol       Date:  2011-01-26       Impact factor: 3.067

4.  CD73 is critical for the resolution of murine colonic inflammation.

Authors:  Margaret S Bynoe; Adam T Waickman; Deeqa A Mahamed; Cynthia Mueller; Jeffrey H Mills; Agnieszka Czopik
Journal:  J Biomed Biotechnol       Date:  2012-10-14

5.  Endoscopy Assessment at 1-Year Identifies Long-Term Responders to Thiopurines Maintenance Therapy in Patients With Crohn's Disease.

Authors:  Yun Qiu; Bai-Li Chen; Ren Mao; Sheng-Hong Zhang; Yao He; Zhi-Rong Zeng; Min-Hu Chen
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

Review 6.  What is the impact of age on adult patients with inflammatory bowel disease?

Authors:  Cristina Cijevschi Prelipcean; Cătălina Mihai; Petruţ Gogalniceanu; Bogdan Mihai
Journal:  Clujul Med       Date:  2013-02-04

7.  Factors associated with the achievement of mucosal healing in Crohn's disease: the benefit of endoscopic monitoring in treating to target.

Authors:  Ren Mao; Yun Qiu; Bai-Li Chen; Sheng-Hong Zhang; Rui Feng; Yao He; Zhi-Rong Zeng; Shomron Ben-Horin; Min-Hu Chen
Journal:  Therap Adv Gastroenterol       Date:  2017-03-28       Impact factor: 4.409

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.